Stay updated with breaking news from Techcyte Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
1:48 After a NanoSpot.AI rapid COVID-19 antibody test has been completed, the person administering the test takes a picture of the test card using a mobile phone. The image is transmitted to Techcyte Inc. for analysis using Techcyte’s artificial intelligence-based image analysis tool. Credit ARUP Laboratories The University of Utah recently partnered with two Utah laboratories to produce an inexpensive coronavirus antibody test, in the form of a mobile app. “There are many tests around that detect antibodies by now. But our aim was to develop something that is fast, that can be done anywh...
May 03, 2021 10:00 AM The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. have formed a partnership to develop NanoSpot.AI, a fast, easy-to-administer SARS-CoV-2 antibody test. The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced today that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests, so it has the potential to be considerably more affordable than currently av...
The patent-pending NanoSpot.AI is performed on a spot of blood obtained through a finger prick, and individuals receive test results on their mobile phones. The test is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests, so it has the potential to be considerably more affordable than currently available tests, making it possible to extend the test to every corner of the world. Clinical studies validating NanoSpot.AI are currently underway.